Form 4: Tandem Diabetes Care Executive Transfers Shares to Family Trust
Insider Ownership Report
Elizabeth Anne Gasser, EVP and Chief Strategy Officer of Tandem Diabetes Care Inc., transferred 11,200 shares of common stock from her direct holdings to The Gasser Family Trust on May 29, 2025.
Summary
- Elizabeth Anne Gasser, Executive Vice President and Chief Strategy Officer of Tandem Diabetes Care Inc. (TNDM), reported a change in beneficial ownership.
- On May 29, 2025, Ms. Gasser transferred 11,200 shares of TNDM common stock from her direct ownership to The Gasser Family Trust.
- The transaction code 'J' indicates an intra-household transfer, not a market sale or purchase.
- Following this transfer, Ms. Gasser's direct beneficial ownership of TNDM common stock is 0 shares.
- The Gasser Family Trust, of which Ms. Gasser is a co-trustee, now indirectly holds 22,949 shares of TNDM common stock.
- The transfer was reported with a price of $0, confirming it was a non-market transaction.
Sentiment
Score: 5
Explanation: Neutral, as this is a routine insider ownership transfer and does not reflect positively or negatively on the company's operational or financial performance.
Positives
- No direct positives for the company's operational or financial performance are indicated by this insider ownership transfer, as it is a change in the form of ownership rather than a market transaction.
Negatives
- No direct negatives for the company's operational or financial performance are indicated by this insider ownership transfer, as it is a change in the form of ownership rather than a market transaction.
Risks
- NA
Future Outlook
NA
Industry Context
This Form 4 filing is a routine disclosure of an insider's change in beneficial ownership and does not provide information related to broader industry trends or competitors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Ownership Structure | Elizabeth Anne Gasser, EVP, Chief Strategy Officer, transferred 11,200 shares of common stock from her direct holdings to The Gasser Family Trust. This changes the form of her beneficial ownership from direct to indirect through a family trust where she is a co-trustee. | 05/29/2025 | This is a routine change in the structure of an insider's beneficial ownership and does not indicate a change in overall control or economic interest by the insider. It reflects personal estate planning rather than a corporate governance shift. |
Related Party Transactions
- The transfer of 11,200 shares of common stock to The Gasser Family Trust, of which Elizabeth A. Gasser is a co-trustee, constitutes a related party transaction in terms of beneficial ownership structure.
Stakeholder Impact
- This transaction is an internal transfer of shares by an executive and is unlikely to have a direct material impact on shareholders, employees, customers, suppliers, or creditors. It primarily affects the reporting structure of the executive's beneficial ownership.
Key Dates
| Date | Description |
|---|---|
| 05/29/2025 | Date of transaction where 11,200 shares were transferred from Elizabeth A. Gasser's direct holdings to The Gasser Family Trust. |
| 06/02/2025 | Date the Form 4 was signed by Rachel Malina, Attorney-in-Fact for Elizabeth A. Gasser. |
Keywords
Tandem Diabetes Care, TNDM, SEC Form 4, Insider Trading, Beneficial Ownership, Stock Transfer, Elizabeth Anne Gasser, Family Trust, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.